SCHEMBL723813

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL771403	0.84	KMT2A (0.54)	GAKSYKCDK2BRD4KIT
	SCHEMBL723277	0.79	MAP3K11 (0.50)	GAKSYKMAP3K11
	SCHEMBL725078	0.76	MAP3K11 (0.50)	GAKBRD4MAP3K11
	SCHEMBL5681169	0.75	SYK (0.50)	GAKSYKJAK2EGFRCDK2
	SCHEMBL31589356	0.75	TNF (0.57)	—
	SCHEMBL5358941	0.75	TNF (0.57)	—
	SCHEMBL1526883	0.73	PLAU (0.55)	DYRK1A
	SCHEMBL6991069	0.73	PLAU (0.55)	PIK3CA
	SCHEMBL29923293	0.73	PLAU (0.55)	DYRK1A
	SCHEMBL723823	0.73	MAP3K11 (0.59)	GAKJAK2EGFRBRD4MAP3K11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.